2m 2m 2m 2m 2m 2m 2m
LIMINATUS-A (LIMN)
NASDAQ
$2.92-$0.02 (-0.68%)
Price as of Nov 12, 2026 8:16 AM EST- $3.9MMarket Cap
- -94.97%1-Year Change
- BiotechnologyIndustry
LIMINATUS-A (LIMN)
$2.92-$0.02 (-0.68%)
LIMN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.94 | ||
Change | +$0.17 (+6.14%) | ||
Open | $2.98 | ||
High | $3.08 | ||
Low | $2.85 | ||
Previous Close | $2.77 | ||
Volume | 27,619 | ||
30-Day Average Volume | 30,813 | ||
1-Week Change | 5.21% | ||
1-Month Change | -21.81% | ||
1-Year Change | -94.97% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.3M | ||
Total Assets | $3.4M | ||
Market Cap | $3.9M | ||
Enterprise Value | $2.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$969,999.00 | ||
EBIT | -$1.4M | ||
EBITDA | -$1.4M | ||
Net Working Capital | $352,044.00 | ||
EPS | -$1.50 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 13 | ||
P/E | -2 | ||
PEG | N/A | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 08/21/2026 | ||
Earnings & Revenue